日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oral Anticoagulant Therapy of Patients With Atrial Fibrillation in Cardiology, Internal Medicine, and Surgery: Temporal Trend

心脏病学、内科学和外科中房颤患者的口服抗凝治疗:时间趋势

Lin, Mingjie; Huang, He; Wang, Juntao; Sun, Hui; Xu, Xingsheng; Zhang, Yan; Han, Wenqiang; Chen, Min; Dong, Kui; Wang, Yingcui; You, Beian; Yao, Guihua; Zhong, Jingquan; Huang, Congxin

Clinical Characteristics and Outcomes of Catheter Ablation in Young Patients With Atrial Fibrillation

年轻房颤患者导管消融术的临床特征和结果

Wang, Xuewen; Cao, Qiqi; Liu, Tao; Zhang, Fan; Zhang, Shujuan; Shi, Shaobo; Zhao, Qingyan; Huang, He; Huang, Congxin

Machine-learning model for predicting left atrial thrombus in patients with paroxysmal atrial fibrillation

用于预测阵发性房颤患者左心房血栓的机器学习模型

Xiong, Wanli; Cao, Qiqi; Jia, Lu; Chen, Min; Liu, Tao; Zhao, Qingyan; Tang, Yanhong; Yang, Bo; Li, Li; Shi, Shaobo; Huang, He; Huang, Congxin

Nonoptimal Temperature Is Associated With Higher Atrial Fibrillation Hospitalizations in China: A Nationwide Case-Crossover Study

中国一项全国性病例交叉研究发现,非适宜体温与较高的房颤住院率相关。

Wang, Shihao; Yang, Xiaolei; Shi, Shaobo; Tang, Yanhong; Wei, Yushan; Sun, Yuanjun; Hidru, Tesfaldet Habtemariam; Yin, Xiaomeng; Wu, Gang; Zhao, Qingyan; Dong, Yingxue; Gao, Lianjun; Tse, Gary; Huang, Congxin; Huang, He; Xia, Yunlong

Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial

经导管消融治疗持续性房颤后,申松养心预防房性心律失常:SS-AFRF试验

Huang, He; Liu, Yu; Shuai, Wei; Jiang, Chenyang; Zhang, Menghe; Qu, Xiufen; Zheng, Wenqing; Yang, Hao; Liu, Fan; Yu, Bo; Chen, Manhua; Mu, Bin; Yao, Chen; Tang, Yanhong; Huang, Congxin; Ouyang, Feifan; Jia, Zhenhua

Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice

苯乙酰谷氨酰胺对超压诱发HF小鼠心房颤动易感性的影响

Hui Fu, Dengke Li, Wei Shuai, Bin Kong, Xi Wang, Yanhong Tang, He Huang, Congxin Huang

2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases

2023年中国专家共识:COVID-19对心血管疾病管理的影响

Bai, Feng; Pu, Jun; Che, Wenliang; Chen, Jiyan; Chen, Mao; Chen, Wei; Chen, Xiaoping; Chen, Yundai; Cheng, Xianwu; Cheng, Xiang; Cong, Hongliang; Dai, Cuilian; Fan, Dali; Fu, Guosheng; Gao, Lei; Gao, Chuanyu; Gao, Wei; Ge, Junbo; He, Ben; Hu, Tao; Huang, Congxin; Huang, Jing; Huo, Yong; Jia, Shaobin; Jiang, Jun; Jing, Zhicheng; Kong, Xiangqing; Li, Lang; Li, Yan; Li, Yigang; Li, Zhijuan; Liang, Chun; Lin, Xianhe; Liu, Xianxia; Liu, Xuebo; Lu, Chengzhi; Ma, Genshan; Ma, Yitong; Mao, Wei; Mei, Xia; Ning, Zhongping; Ou, Jiafu; Slaj, Shaderdin; Shen, Chengxing; Shi, Haiming; Shi, Hong; Shi, Bei; Su, Xi; Sun, Ningling; Tang, Qizhu; Wang, Fang; Wang, Changqian; Wang, Jin; Wu, Yanqing; Wu, Yongjian; Xia, Yunlong; Xiang, Dingcheng; Xiao, Pingxi; Xie, Ping; Xiong, Dingding; Xu, Yawei; Yang, Jiefu; Yang, Lixia; Yu, Zaixin; Yuan, Zuyi; Yuan, Haitao; Zhang, Guogang; Zhang, Heng; Zhang, Jian; Zhang, Li; Zhang, Ruiyan; Zhang, Shuning; Zhang, Shuyang; Zhang, Zheng; Zhao, Guoan; Zhao, Xianxian; Zheng, Jingang; Zheng, Haoyi; Zhou, Daxin; Zhou, Shenghua; Zhou, Yujie

Correction: Dapaglifozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling

更正:达格列净通过恢复钙离子处理,降低肺动脉高压诱发右心衰竭大鼠发生室性心律失常的风险。

Wu, Jinchun; Liu, Tao; Shi, Shaobo; Fan, Zhixing; Hiram, Roddy; Xiong, Feng; Cui, Bo; Su, Xiaoling; Chang, Rong; Zhang, Wei; Yan, Min; Tang, Yanhong; Huang, He; Wu, Gang; Huang, Congxin

[Corrigendum] MicroRNA‑24 attenuates diabetic vascular remodeling by suppressing the NLRP3/caspase‑1/IL‑1β signaling pathway

【更正】MicroRNA-24通过抑制NLRP3/caspase-1/IL-1β信号通路减轻糖尿病血管重塑

Fan, Zhixing; Yang, Jian; Yang, Chaojun; Zhang, Jing; Cai, Wanying; Huang, Congxin

Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China

中国一项关于非瓣膜性房颤患者左心房血栓的横断面研究

Shi, Shaobo; Zhao, Qingyan; Liu, Tao; Zhang, Shujuan; Liang, Jinjun; Tang, Yanhong; Yang, Bo; Huang, He; Huang, Congxin